<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-vaccines-08-00307">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cabral-Miranda</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lim</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Mohsen</surname>
    <given-names>M.O.</given-names>
   </name>
   <name>
    <surname>Pobelov</surname>
    <given-names>I.V.</given-names>
   </name>
   <name>
    <surname>Roesti</surname>
    <given-names>E.S.</given-names>
   </name>
   <name>
    <surname>Heath</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Skinner</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Kramer</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Martina</surname>
    <given-names>B.E.E.</given-names>
   </name>
   <name>
    <surname>Bachmann</surname>
    <given-names>M.F.</given-names>
   </name>
  </person-group>
  <article-title>Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection</article-title>
  <source>Vaccines (Basel)</source>
  <year>2019</year>
  <volume>7</volume>
  <elocation-id>72</elocation-id>
  <pub-id pub-id-type="doi">10.3390/vaccines7030072</pub-id>
  <?supplied-pmid 31340594?>
  <pub-id pub-id-type="pmid">31340594</pub-id>
 </element-citation>
</ref>
